Cargando…

Full ablation of C9orf72 in mice causes immune system-related pathology and neoplastic events but no motor neuron defects

Detalles Bibliográficos
Autores principales:	Sudria-Lopez, Emma, Koppers, Max, de Wit, Marina, van der Meer, Christiaan, Westeneng, Henk-Jan, Zundel, Caroline A. C., Youssef, Sameh A., Harkema, Liesbeth, de Bruin, Alain, Veldink, Jan H., van den Berg, Leonard H., Pasterkamp, R. Jeroen
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Berlin Heidelberg 2016
Materias:	Correspondence
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4911370/ https://www.ncbi.nlm.nih.gov/pubmed/27206760 http://dx.doi.org/10.1007/s00401-016-1581-x

Ejemplares similares

C9orf72 ablation in mice does not cause motor neuron degeneration or motor deficits
por: Koppers, Max, et al.
Publicado: (2015)

Widespread structural brain involvement in ALS is not limited to the C9orf72 repeat expansion
por: Westeneng, Henk-Jan, et al.
Publicado: (2016)

Novel antibodies reveal presynaptic localization of C9orf72 protein and reduced protein levels in C9orf72 mutation carriers
por: Frick, Petra, et al.
Publicado: (2018)

Unaffected mosaic C9orf72 case: RNA foci, dipeptide proteins, but upregulated C9orf72 expression
por: McGoldrick, Philip, et al.
Publicado: (2018)

Measuring and Interpreting Nuclear Transport in Neurodegenerative Disease—The Example of C9orf72 ALS
por: Semmelink, Marije F. W., et al.
Publicado: (2021)

Roadmap for C9ORF72 in Frontotemporal Dementia and Amyotrophic Lateral Sclerosis: Report on the C9ORF72 FTD/ALS Summit
por: Sattler, Rita, et al.
Publicado: (2023)

Use of Multimodal Imaging and Clinical Biomarkers in Presymptomatic Carriers of C9orf72 Repeat Expansion
por: De Vocht, Joke, et al.
Publicado: (2020)

Acute systemic loss of Mad2 leads to intestinal atrophy in adult mice
por: Schukken, Klaske M., et al.
Publicado: (2021)

Treatment implications of C9ORF72
por: Sha, Sharon J, et al.
Publicado: (2012)

Sensitivity of brain MRI and neurological examination for detection of upper motor neurone degeneration in amyotrophic lateral sclerosis
por: Nitert, Abram D, et al.
Publicado: (2022)

Cross-sectional and longitudinal assessment of the upper cervical spinal cord in motor neuron disease
por: van der Burgh, Hannelore K., et al.
Publicado: (2019)

Eye movement alterations in presymptomatic C9orf72 expansion gene carriers
por: Behler, Anna, et al.
Publicado: (2021)

Neuroimaging features of C9ORF72 expansion
por: Yokoyama, Jennifer S, et al.
Publicado: (2012)

C9orf72 immunohistochemistry in Alzheimer's disease
por: Hortobágyi, Tibor
Publicado: (2012)

The Enigmatic Role of C9ORF72 in Autophagy
por: Nassif, Melissa, et al.
Publicado: (2017)

Moderate intrinsic phenotypic alterations in C9orf72 ALS/FTD iPSC-microglia despite the presence of C9orf72 pathological features
por: Lorenzini, Ileana, et al.
Publicado: (2023)

Neuronal Transcriptome from C9orf72 Repeat Expanded Human Tissue is Associated with Loss of C9orf72 Function
por: Liu, Elaine Y., et al.
Publicado: (2020)

Letter to the editor on a paper by Kaivola et al. (2020): carriership of two copies of C9orf72 hexanucleotide repeat intermediate-length alleles is not associated with amyotrophic lateral sclerosis or frontotemporal dementia
por: de Boer, Sterre C. M., et al.
Publicado: (2022)

Whole blood transcriptome analysis in amyotrophic lateral sclerosis: A biomarker study
por: van Rheenen, Wouter, et al.
Publicado: (2018)

The repeat length of C9orf72 is associated with the survival of amyotrophic lateral sclerosis patients without C9orf72 pathological expansions
por: Tang, Lu, et al.
Publicado: (2022)

Genetic modifiers in carriers of repeat expansions in the C9ORF72 gene
por: van Blitterswijk, Marka, et al.
Publicado: (2014)

C9ORF72 expansion in a family with bipolar disorder
por: Meisler, Miriam H, et al.
Publicado: (2013)

Gyrification abnormalities in presymptomatic c9orf72 expansion carriers
por: Caverzasi, Eduardo, et al.
Publicado: (2019)

A comparative bioinformatic analysis of C9orf72
por: Iyer, Shalini, et al.
Publicado: (2018)

RNA Misprocessing in C9orf72-Linked Neurodegeneration
por: Barker, Holly V., et al.
Publicado: (2017)

Clinical features of TBK1 carriers compared with C9orf72, GRN and non-mutation carriers in a Belgian cohort
por: Van Mossevelde, Sara, et al.
Publicado: (2016)

Unravelling the clinical spectrum and the role of repeat length in C9ORF72 repeat expansions
por: van der Ende, Emma L., et al.
Publicado: (2021)

Phase Separation of C9orf72 Dipeptide Repeats Perturbs Stress Granule Dynamics
por: Boeynaems, Steven, et al.
Publicado: (2017)

Microglia in frontotemporal lobar degeneration with progranulin or C9ORF72 mutations
por: Sakae, Nobutaka, et al.
Publicado: (2019)

Differences in Cerebral Glucose Metabolism in ALS Patients with and without C9orf72 and SOD1 Mutations
por: De Vocht, Joke, et al.
Publicado: (2023)

A new inducible transgenic mouse model for C9orf72-associated GGGGCC repeat expansion supports a gain-of-function mechanism in C9orf72-associated ALS and FTD
por: Hukema, Renate K, et al.
Publicado: (2014)

In vivo histopathological staging in C9orf72-associated ALS: A tract of interest DTI study
por: Müller, Hans-Peter, et al.
Publicado: (2020)

A C6orf10/LOC101929163 locus is associated with age of onset in C9orf72 carriers
por: Zhang, Ming, et al.
Publicado: (2018)

Abnormal expression of homeobox genes and transthyretin in C9ORF72 expansion carriers
por: Finch, NiCole A., et al.
Publicado: (2017)

C9orf72 is differentially expressed in the central nervous system and myeloid cells and consistently reduced in C9orf72, MAPT and GRN mutation carriers
por: Rizzu, Patrizia, et al.
Publicado: (2016)

A blinded international study on the reliability of genetic testing for GGGGCC-repeat expansions in C9orf72 reveals marked differences in results among 14 laboratories
por: Akimoto, Chizuru, et al.
Publicado: (2014)

Poly(GP), neurofilament and grey matter deficits in C9orf72 expansion carriers
por: Meeter, Lieke H.H., et al.
Publicado: (2018)

HNRNPK alleviates RNA toxicity by counteracting DNA damage in C9orf72 ALS
por: Braems, Elke, et al.
Publicado: (2022)

C9orf72 in myeloid cells suppresses STING-induced inflammation
por: McCauley, Madelyn E., et al.
Publicado: (2020)

Structure of the C9orf72 Arf GAP complex haploinsufficient in ALS and FTD
por: Su, Ming-Yuan, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_48trh6ion1qh85s8273e6gq8ee